Logo image of RZLV

REZOLVE AI PLC (RZLV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:RZLV - GB00BQH8G337 - Common Stock

3.68 USD
-0.03 (-0.81%)
Last: 1/9/2026, 8:25:08 PM
3.8 USD
+0.12 (+3.26%)
After Hours: 1/9/2026, 8:25:08 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to RZLV. RZLV was compared to 276 industry peers in the Software industry. Both the profitability and financial health of RZLV have multiple concerns. RZLV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RZLV had negative earnings in the past year.
In the past year RZLV has reported a negative cash flow from operations.
In the past 5 years RZLV always reported negative net income.
In the past 5 years RZLV always reported negative operating cash flow.
RZLV Yearly Net Income VS EBIT VS OCF VS FCFRZLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -215.53%, RZLV is doing worse than 97.10% of the companies in the same industry.
Industry RankSector Rank
ROA -215.53%
ROE N/A
ROIC N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RZLV Yearly ROA, ROE, ROICRZLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

With an excellent Gross Margin value of 81.84%, RZLV belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for RZLV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RZLV Yearly Profit, Operating, Gross MarginsRZLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

More info and screens

0

2. Health

2.1 Basic Checks

RZLV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RZLV has been increased compared to 1 year ago.
Compared to 1 year ago, RZLV has a worse debt to assets ratio.
RZLV Yearly Shares OutstandingRZLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M
RZLV Yearly Total Debt VS Total AssetsRZLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

RZLV has an Altman-Z score of -4.68. This is a bad value and indicates that RZLV is not financially healthy and even has some risk of bankruptcy.
RZLV has a Altman-Z score of -4.68. This is amonst the worse of the industry: RZLV underperforms 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.68
ROIC/WACCN/A
WACC9.61%
RZLV Yearly LT Debt VS Equity VS FCFRZLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.24 indicates that RZLV may have some problems paying its short term obligations.
With a Current ratio value of 0.24, RZLV is not doing good in the industry: 96.38% of the companies in the same industry are doing better.
A Quick Ratio of 0.24 indicates that RZLV may have some problems paying its short term obligations.
RZLV has a worse Quick ratio (0.24) than 96.01% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.24
RZLV Yearly Current Assets VS Current LiabilitesRZLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

3

3. Growth

3.1 Past

RZLV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2570.28%.
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-189.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%425.54%

3.2 Future

Based on estimates for the next years, RZLV will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.94% on average per year.
Based on estimates for the next years, RZLV will show a very strong growth in Revenue. The Revenue will grow by 984.87% on average per year.
EPS Next Y-159.05%
EPS Next 2Y-4.2%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue Next Year15560.9%
Revenue Next 2Y2514.98%
Revenue Next 3Y984.87%
Revenue Next 5YN/A

3.3 Evolution

RZLV Yearly Revenue VS EstimatesRZLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 100M 200M 300M
RZLV Yearly EPS VS EstimatesRZLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RZLV. In the last year negative earnings were reported.
Also next year RZLV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RZLV Price Earnings VS Forward Price EarningsRZLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RZLV Per share dataRZLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as RZLV's earnings are expected to grow with 18.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.2%
EPS Next 3Y18.94%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RZLV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

REZOLVE AI PLC

NASDAQ:RZLV (1/9/2026, 8:25:08 PM)

After market: 3.8 +0.12 (+3.26%)

3.68

-0.03 (-0.81%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-24 2025-04-24
Earnings (Next)N/A N/A
Inst Owners24.32%
Inst Owner ChangeN/A
Ins Owners28.15%
Ins Owner ChangeN/A
Market Cap1.19B
Revenue(TTM)187.80K
Net Income(TTM)-172.65M
Analysts81.67
Price Target10.8 (193.48%)
Short Float %11.38%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)36.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)-0.74%
EPS NY rev (3m)6.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6313.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS-0.04
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -215.53%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.84%
FCFM N/A
ROA(3y)-292.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 237.53%
Cap/Sales 2093.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.24
Altman-Z -4.68
F-Score5
WACC9.61%
ROIC/WACCN/A
Cap/Depr(3y)772.08%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2570.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-189.03%
EPS Next Y-159.05%
EPS Next 2Y-4.2%
EPS Next 3Y18.94%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%425.54%
Revenue Next Year15560.9%
Revenue Next 2Y2514.98%
Revenue Next 3Y984.87%
Revenue Next 5YN/A
EBIT growth 1Y-4849.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-12.99%
EBIT Next 3Y50.8%
EBIT Next 5YN/A
FCF growth 1Y-4777.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4304.11%
OCF growth 3YN/A
OCF growth 5YN/A

REZOLVE AI PLC / RZLV FAQ

What is the ChartMill fundamental rating of REZOLVE AI PLC (RZLV) stock?

ChartMill assigns a fundamental rating of 1 / 10 to RZLV.


What is the valuation status for RZLV stock?

ChartMill assigns a valuation rating of 0 / 10 to REZOLVE AI PLC (RZLV). This can be considered as Overvalued.


What is the profitability of RZLV stock?

REZOLVE AI PLC (RZLV) has a profitability rating of 1 / 10.


Can you provide the financial health for RZLV stock?

The financial health rating of REZOLVE AI PLC (RZLV) is 0 / 10.


What is the expected EPS growth for REZOLVE AI PLC (RZLV) stock?

The Earnings per Share (EPS) of REZOLVE AI PLC (RZLV) is expected to decline by -159.05% in the next year.